Literature DB >> 9028967

Negative regulation of the erythropoietin gene expression by the GATA transcription factors.

S Imagawa1, M Yamamoto, Y Miura.   

Abstract

We examined regulation of the human erythropoietin (Epo) gene through the GATA sequence in the Epo promoter and showed that Hep3B and HepG2 cells express human GATA-2 (hGATA-2) mRNA and protein. Nuclear extracts of QT6 cells transfected with hGATA-1, 2, or 3 transcription factors showed specific binding to the GATA element in the human Epo gene promoter by gel mobility shift assay. Transient transfection of Hep3B cells with hGATA-1, 2, or 3 showed that each of these transcription factors significantly decreased the level of expression of Epo mRNA as assessed by a competitive polymerase chain reaction. Transient transfection of Hep3B cells with hGATA-1, 2, and 3 and an Epo-reporter gene (growth hormone [GH]) construct showed significant inhibition of the Epo promoter. Antisense oligonucleotide for hGATA-2 transcription factor significantly increased the Epo protein in Hep3B cells under 1% O2 for 24 hours incubation. Furthermore, transient transfection of Hep3B cells with hGATA-1, 2, and 3 and an Epo-reporter gene (luciferase) construct also showed significant inhibition of the Epo promoter. However, transfection of the mutated GATA sequence of the Epo-luciferase gene with hGATA-1, 2, and 3 interfere with the inhibition of the Epo promoter. We conclude that the hGATA-1, 2, and 3 transcription factors specifically bind to the GATA element in the human Epo gene promoter and negatively regulate Epo gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028967

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Charge movement and transcription regulation of L-type calcium channel alpha(1S) in skeletal muscle cells.

Authors:  Zhenlin Zheng; Zhong-Min Wang; Osvaldo Delbono
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

2.  GATA1 function, a paradigm for transcription factors in hematopoiesis.

Authors:  Rita Ferreira; Kinuko Ohneda; Masayuki Yamamoto; Sjaak Philipsen
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

3.  Single-nucleotide polymorphisms in CD8A and their associations with T lymphocyte subpopulations in pig.

Authors:  Wenwen Wang; Yang Liu; Weixuan Fu; Jingen Xu; Jianfeng Liu; Xiangdong Ding; Qin Zhang
Journal:  Mol Genet Genomics       Date:  2015-02-19       Impact factor: 3.291

4.  Tissue factor inflammatory response regulated by promoter genotype and p38 MAPK in neonatal vs. adult microvascular endothelial cells.

Authors:  Jeffrey S Buzby; Shirley A Williams; Karen L Imfeld; Thomas J Kunicki; Diane J Nugent
Journal:  Inflamm Res       Date:  2014-01-03       Impact factor: 4.575

5.  Down-regulation of GATA-2 transcription during Pneumocystis carinii infection.

Authors:  X Tang; M E Lasbury; D D Davidson; M S Bartlett; J W Smith; C H Lee
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  L-arginine administration reverses anemia associated with renal disease.

Authors:  Takahisa Tarumoto; Shigehiko Imagawa; Makoto Kobayashi; Aki Hirayama; Keiya Ozawa; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 7.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

8.  Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.

Authors:  Mark E Lasbury; Xing Tang; Pamela J Durant; Chao-Hung Lee
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 9.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

Review 10.  Survival and proliferative roles of erythropoietin beyond the erythroid lineage.

Authors:  Constance Tom Noguchi; Li Wang; Heather M Rogers; Ruifeng Teng; Yi Jia
Journal:  Expert Rev Mol Med       Date:  2008-12-01       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.